A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy…

Overview of attention for article published in Journal of Travel Medicine, December 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 9 news outlets
blogs: 1 blog

twitter: 8 X users
reddit: 1 Redditor

Readers on

mendeley: 53 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 13,096 followers.

זה נראה שהחיסון נגד ליים עבר שלב 3

RT @valnevaSE: We are pleased to announce that data from our lot-to-lot consistency trial for chikungunya vaccine candidate VLA1553 have be…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.